Founded by William G. Fredrick in 1980, Laser Mechanisms originated in Detroit, Michigan, USA to pioneer in innovative solutions for industrial laser materials processing. The modular concept of providing easy to integrate laser beam delivery components to OEMs, system integrators, laser machine builders, production companies integrating lasers including medical system builders and medical device manufacturers, has evolved into a very broad product range to serve the worldwide market place. With corporate offices, sales, engineering and application support services located in USA, sales and service headquarters in Europe, China, Mexico & Taiwan, distributors, product and service representatives across the globe, Laser Mechanisms is firmly positioned to support its global customer base.
Laser processing solutions from Laser Mech are available for a variety of lasers spanning CO2, Fiber, Disk, Er-YAG, Diode and Excimer lasers.
Market segments include robotic cutting in 3d, sheet metal cutting/welding in 2d & 3d, additive manufacturing cells with powder/wire, medical system solutions, micro machining of medical devices and processing solutions for the automotive industry.
Pro Engineer being our backbone for advanced engineering design offers 3d design capability to complement the conformance to Laser Mech’s stringent manufacturing standards. By maintaining a high standard for manufacturing precision, all Laser Mech parts deliver unmatched repeatability, durability and reliability.
Every beam delivery component Laser Mech builds goes through a rigorous testing procedure that is designed to meet or exceed all current Quality Control certifications. Our medical manufacturing adheres to the FDA’s current Good Manufacturing Practices (cGMP), and is registered as a contract manufacturer of medical devices with the FDA/CDRH. Laser Mechanisms medical device products, for sale in the European common market, are engineered and tested in conformance with the required European Council Directives that allow them to carry the CE Mark.